Vegetable Compound Found to Protect Against Radiation
By MedImaging International staff writers Posted on 28 Oct 2013 |
Researchers have reported that a compound found in cruciferous vegetable such as cauliflower, cabbage, and broccoli shields rats and mice from lethal doses of radiation.
Their study, published October 15, 2013, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) suggests the compound, already demonstrated to be safe for humans, may protect healthy tissues during radiotherapy for cancer treatment and prevent or lessen sickness caused by radiation exposure.
The compound, known as DIM (3,3'-diindolylmethane), previously has been found to have cancer preventive properties. “DIM has been studied as a cancer prevention agent for years, but this is the first indication that DIM can also act as a radiation protector,” stated the study’s corresponding author, Eliot Rosen, MD, PhD, of Georgetown University Lombardi Comprehensive Cancer Center (Washington DC, USA).
The scientists irradiated rats in the study with lethal doses of gamma ray radiation. The animals were then treated with a daily injection of DIM for two weeks, starting 10 minutes after the radiation exposure. The result was amazing, according to Dr. Rosen, a professor of oncology, biochemistry, cell and molecular biology, and radiation medicine. “All of the untreated rats died, but well over half of the DIM-treated animals remained alive 30 days after the radiation exposure.”
Dr. Rosen added that DIM also provided protection whether the first injection was administered 24 hours before or up to 24 hours after radiation exposure. “We also showed that DIM protects the survival of lethally irradiated mice,” Dr. Rosen said. Furthermore, irradiated mice treated with DIM had less reduction in red blood cells, white blood cells and platelets—side effects often seen in patients undergoing radiation treatment for cancer.
Dr. Rosen noted that this study revealed two potential uses of the compound. “DIM could protect normal tissues in patients receiving radiation therapy for cancer, but could also protect individuals from the lethal consequences of a nuclear disaster.”
Rosen and study coauthors Saijun Fan, PhD, and Milton Brown, MD, PhD, are co-inventors on a patent application that has been filed by Georgetown University for the use of DIM and DIM-related compounds as radioprotectors.
Related Links:
Georgetown University Lombardi Comprehensive Cancer Center
Their study, published October 15, 2013, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) suggests the compound, already demonstrated to be safe for humans, may protect healthy tissues during radiotherapy for cancer treatment and prevent or lessen sickness caused by radiation exposure.
The compound, known as DIM (3,3'-diindolylmethane), previously has been found to have cancer preventive properties. “DIM has been studied as a cancer prevention agent for years, but this is the first indication that DIM can also act as a radiation protector,” stated the study’s corresponding author, Eliot Rosen, MD, PhD, of Georgetown University Lombardi Comprehensive Cancer Center (Washington DC, USA).
The scientists irradiated rats in the study with lethal doses of gamma ray radiation. The animals were then treated with a daily injection of DIM for two weeks, starting 10 minutes after the radiation exposure. The result was amazing, according to Dr. Rosen, a professor of oncology, biochemistry, cell and molecular biology, and radiation medicine. “All of the untreated rats died, but well over half of the DIM-treated animals remained alive 30 days after the radiation exposure.”
Dr. Rosen added that DIM also provided protection whether the first injection was administered 24 hours before or up to 24 hours after radiation exposure. “We also showed that DIM protects the survival of lethally irradiated mice,” Dr. Rosen said. Furthermore, irradiated mice treated with DIM had less reduction in red blood cells, white blood cells and platelets—side effects often seen in patients undergoing radiation treatment for cancer.
Dr. Rosen noted that this study revealed two potential uses of the compound. “DIM could protect normal tissues in patients receiving radiation therapy for cancer, but could also protect individuals from the lethal consequences of a nuclear disaster.”
Rosen and study coauthors Saijun Fan, PhD, and Milton Brown, MD, PhD, are co-inventors on a patent application that has been filed by Georgetown University for the use of DIM and DIM-related compounds as radioprotectors.
Related Links:
Georgetown University Lombardi Comprehensive Cancer Center
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection